Explore more publications!
Cyprus Healthcare Press
Submit Press Release

Cyprus Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 20, 2025

Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids
November 20, 2025

Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids

Indeterminate GlobeNewswire
CHRISTUS Health recognized as ‘Most Wired’ health provider for digital transformation
November 20, 2025

CHRISTUS Health recognized as ‘Most Wired’ health provider for digital transformation

Indeterminate GlobeNewswire
BioSyent Releases Financial Results for Q3 and YTD 2025
November 20, 2025

BioSyent Releases Financial Results for Q3 and YTD 2025

Indeterminate GlobeNewswire
BioSyent Declares Fourth Quarter 2025 Dividend
November 20, 2025

BioSyent Declares Fourth Quarter 2025 Dividend

Indeterminate GlobeNewswire
Regional Health Properties Reports Third Quarter 2025 Results Following Completion of Merger with SunLink Health Systems, Inc.
November 20, 2025

Regional Health Properties Reports Third Quarter 2025 Results Following Completion of Merger with SunLink Health Systems, Inc.

Indeterminate GlobeNewswire
Equillium to Participate in Upcoming Investor Conferences
November 20, 2025

Equillium to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Information on the total number of voting rights and shares
November 20, 2025

Information on the total number of voting rights and shares

Indeterminate GlobeNewswire
Informations sur le nombre total de droits de vote et d'actions
November 20, 2025

Informations sur le nombre total de droits de vote et d'actions

Indeterminate GlobeNewswire
Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
November 20, 2025

Inhibikase Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference
November 20, 2025

CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

Indeterminate GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
November 20, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update
November 20, 2025

Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Crinetics Announces First Patient Randomized in Pivotal Phase 3 CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome
November 20, 2025

Crinetics Announces First Patient Randomized in Pivotal Phase 3 CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome

Indeterminate GlobeNewswire
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference
November 20, 2025

RxSight, Inc. to Present at the Piper Sandler Healthcare Conference

Indeterminate GlobeNewswire
Zevra Therapeutics, Inc. Announces CFO Transition
November 20, 2025

Zevra Therapeutics, Inc. Announces CFO Transition

Indeterminate GlobeNewswire
PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
November 20, 2025

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

Indeterminate GlobeNewswire
Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension
November 20, 2025

Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension

Indeterminate GlobeNewswire
Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference
November 20, 2025

Cognition Therapeutics to Participate in 37th Annual Piper Sandler Healthcare Conference

Indeterminate GlobeNewswire
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
November 20, 2025

Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Pasithea Therapeutics Announces Positive Phase 1 Data Including Partial Response, Demonstrating Monotherapy Clinical Activity and Favorable Safety Profile for PAS-004 in Advanced Cancer Study
November 20, 2025

Pasithea Therapeutics Announces Positive Phase 1 Data Including Partial Response, Demonstrating Monotherapy Clinical Activity and Favorable Safety Profile for PAS-004 in Advanced Cancer Study

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions